Commonwealth Equity Services, LLC Revance Therapeutics, Inc. Transaction History

Commonwealth Equity Services, LLC

$66 Billion
Q3 2024

A detailed history of Commonwealth Equity Services, LLC transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 78,041 shares of RVNC stock, worth $200,565. This represents 0.0% of its overall portfolio holdings.

Number of Shares

78,041

Previous 109,917 29.0%

Holding current value

$200,565

Previous $282,000 43.62%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$2.57 - $2.57 $81,921 - $81,921	-31,876 Reduced 29.0%	78,041 $405,000
Q2 2024 Jul 31, 2024	BUY	$2.34 - $4.73 $3,605 - $7,288	1,541 Added 1.42%	109,917 $282,000
Q1 2024 Apr 29, 2024	SELL	$4.65 - $9.31 $12,871 - $25,770	-2,768 Reduced 2.49%	108,376 $533,000
Q4 2023 Feb 06, 2024	BUY	$5.81 - $11.2 $69,807 - $134,568	12,015 Added 12.12%	111,144 $977,000
Q3 2023 Oct 23, 2023	BUY	$11.47 - $25.07 $39,892 - $87,193	3,478 Added 3.64%	99,129 $1.14 Million
Q2 2023 Aug 10, 2023	BUY	$24.7 - $37.61 $170,010 - $258,869	6,883 Added 7.75%	95,651 $2.42 Million
Q1 2023 May 11, 2023	SELL	$18.36 - $35.27 $936 - $1,798	-51 Reduced 0.06%	88,768 $2.86 Million
Q4 2022 Feb 07, 2023	BUY	$18.32 - $30.66 $238,050 - $398,396	12,994 Added 17.14%	88,819 $1.64 Million
Q3 2022 Nov 14, 2022	BUY	$14.33 - $28.47 $616,361 - $1.22 Million	43,012 Added 131.08%	75,825 $2.05 Million
Q2 2022 Jul 19, 2022	BUY	$11.52 - $20.4 $28,800 - $51,000	2,500 Added 8.25%	32,813 $453,000
Q1 2022 May 04, 2022	BUY	$12.36 - $20.31 $69,191 - $113,695	5,598 Added 22.65%	30,313 $591,000
Q4 2021 Jan 31, 2022	BUY	$12.46 - $27.87 $44,295 - $99,077	3,555 Added 16.8%	24,715 $403,000
Q3 2021 Oct 29, 2021	BUY	$25.78 - $33.21 $155,272 - $200,023	6,023 Added 39.79%	21,160 $589,000
Q2 2021 Aug 11, 2021	SELL	$26.8 - $31.84 $3,966 - $4,712	-148 Reduced 0.97%	15,137 $448,000
Q1 2021 May 04, 2021	BUY	$24.03 - $29.97 $50,535 - $63,026	2,103 Added 15.95%	15,285 $427,000
Q4 2020 Feb 11, 2021	BUY	$23.41 - $28.34 $13,765 - $16,663	588 Added 4.67%	13,182 $373,000
Q3 2020 Nov 05, 2020	BUY	$23.23 - $34.3 $292,558 - $431,974	12,594 New	12,594 $316,000

Others Institutions Holding RVNC

# of Institutions

234

Shares Held

82.8M

Call Options Held

680K

Put Options Held

896K

View Full List

About Revance Therapeutics, Inc.

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

More about RVNC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Account

Commonwealth Equity Services, LLC Revance Therapeutics, Inc. Transaction History